These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30116333)

  • 1. LAP
    Ou X; Guan J; Chen JS; Ying JC; Liu XP; Tian PK; Liu JK; Nie LP; Zhao Y; Yu GY
    Exp Ther Med; 2018 Aug; 16(2):788-796. PubMed ID: 30116333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
    Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH
    Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma sB7-H3 serves as an assistant diagnostic marker for hepatitis B virus-associated hepatocellular carcinoma].
    Xu W; Li F; Yu L; Liu J; He X; Fan R; Chen W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):744-7. PubMed ID: 25001942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunity.
    Wan YL; Zheng SS; Zhao ZC; Li MW; Jia CK; Zhang H
    World J Gastroenterol; 2004 Jan; 10(2):195-9. PubMed ID: 14716821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of LAP
    Zhong W; Jiang ZY; Zhang L; Huang JH; Wang SJ; Liao C; Cai B; Chen LS; Zhang S; Guo Y; Cao YF; Gao F
    World J Gastroenterol; 2017 Jan; 23(3):455-463. PubMed ID: 28210081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired function of CD4+ T follicular helper (Tfh) cells associated with hepatocellular carcinoma progression.
    Jia Y; Zeng Z; Li Y; Li Z; Jin L; Zhang Z; Wang L; Wang FS
    PLoS One; 2015; 10(2):e0117458. PubMed ID: 25689070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
    Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
    Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of regulatory T cells proportion in the peripheral blood and tumor tissue in primary hepatocellular carcinoma].
    Li SP; Peng QQ; Ding T; Xu J; Zhang CQ; Feng KT; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):523-7. PubMed ID: 19062720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phenotypic characteristics of LAP(+) CD4(+) T lymphocytes in colorectal cancer tissues].
    Zhong W; Jiang ZY; Zhong SB; Zhang LC; Huang JH; Zhang S; Chen LS; Cao YF
    Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):596-601. PubMed ID: 27531479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+CD25+CD127(low) Regulatory T Cells Play Predominant Anti-Tumor Suppressive Role in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Sharma S; Khosla R; David P; Rastogi A; Vyas A; Singh D; Bhardwaj A; Sahney A; Maiwall R; Sarin SK; Trehanpati N
    Front Immunol; 2015; 6():49. PubMed ID: 25767469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The presence and the significance of CD4+CD25+ regulatory T cells in livers of patients with hepatocellular carcinoma].
    Yang XH; Liu BR; Jiang HC
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):279-82. PubMed ID: 17456316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The frequency, phenotypes and functions of CD4+ CD25+ regulatory T cells in hepatocellular carcinoma patients].
    Zhang HH; Fei R; Mei MH; Liao WJ; Wang XY; Cong X; Qin LL; Ji Y; Wang SX; Wei L; Chen HS
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):266-72. PubMed ID: 17456313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.
    Zhu J; Feng A; Sun J; Jiang Z; Zhang G; Wang K; Hu S; Qu X
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.
    Yang XH; Yamagiwa S; Ichida T; Matsuda Y; Sugahara S; Watanabe H; Sato Y; Abo T; Horwitz DA; Aoyagi Y
    J Hepatol; 2006 Aug; 45(2):254-62. PubMed ID: 16600416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LAP+CD4+ T cells are suppressors accumulated in the tumor sites and associated with the progression of colorectal cancer.
    Mahalingam J; Lin YC; Chiang JM; Su PJ; Fang JH; Chu YY; Huang CT; Chiu CT; Lin CY
    Clin Cancer Res; 2012 Oct; 18(19):5224-33. PubMed ID: 22879386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of hepatocellular carcinoma growth via oral immune regulation towards tumor-associated antigens is associated with increased NKT and CD8+ lymphocytes.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Oncology; 2004; 66(4):323-30. PubMed ID: 15218301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different expression of apoptotic proteins between HBV-infected and non-HBV-infected hepatocellular carcinoma.
    Chang CS; Huang SM; Lin HH; Wu CC; Wang CJ
    Hepatogastroenterology; 2007; 54(79):2061-8. PubMed ID: 18251160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.